Chemoinformaics analysis of 7,10-Octadecadienoic acid, methyl ester
| Molecular Weight | 294.479 | nRot | 14 |
| Heavy Atom Molecular Weight | 260.207 | nRig | 3 |
| Exact Molecular Weight | 294.256 | nRing | 0 |
| Solubility: LogS | -5.954 | nHRing | 0 |
| Solubility: LogP | 6.412 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 55 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 21 | No. of Aromatic Carbocycles | 0 |
| nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 34 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 19 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 2 | No. of Arom Bond | 0 |
| nHA | 2 | APOL | 56.005 |
| nHD | 0 | BPOL | 36.713 |
| QED | 0.224 |
| Synth | 2.313 |
| Natural Product Likeliness | 1.03 |
| NR-PPAR-gamma | 0.056 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.02 |
| Pgp-sub | 0.002 |
| HIA | 0.043 |
| CACO-2 | -4.796 |
| MDCK | 0.0000317 |
| BBB | 0.146 |
| PPB | 0.998689 |
| VDSS | 3.059 |
| FU | 0.0086054 |
| CYP1A2-inh | 0.814 |
| CYP1A2-sub | 0.231 |
| CYP2c19-inh | 0.558 |
| CYP2c19-sub | 0.064 |
| CYP2c9-inh | 0.487 |
| CYP2c9-sub | 0.974 |
| CYP2d6-inh | 0.628 |
| CYP2d6-sub | 0.418 |
| CYP3a4-inh | 0.741 |
| CYP3a4-sub | 0.075 |
| CL | 3.484 |
| T12 | 0.79 |
| hERG | 0.174 |
| Ames | 0.002 |
| ROA | 0.008 |
| SkinSen | 0.966 |
| Carcinogencity | 0.062 |
| EI | 0.951 |
| Respiratory | 0.72 |
| NR-Aromatase | 0.067 |
| Antiviral | No |
| Prediction | 0.599226 |